Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$34.32 - $57.55 $7,996 - $13,409
-233 Reduced 3.66%
6,138 $343,000
Q3 2023

Nov 02, 2023

SELL
$40.86 - $62.98 $3,759 - $5,794
-92 Reduced 1.42%
6,371 $262,000
Q2 2023

Aug 08, 2023

SELL
$50.96 - $58.72 $12,841 - $14,797
-252 Reduced 3.75%
6,463 $360,000
Q4 2022

Feb 08, 2023

BUY
$24.4 - $41.3 $163,846 - $277,329
6,715 New
6,715 $0
Q2 2022

Aug 05, 2022

SELL
$36.95 - $82.41 $156,446 - $348,923
-4,234 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$55.7 - $145.79 $23,839 - $62,398
428 Added 11.25%
4,234 $322,000
Q4 2021

Feb 02, 2022

BUY
$135.05 - $182.59 $63,068 - $85,269
467 Added 13.99%
3,806 $567,000
Q3 2021

Nov 10, 2021

SELL
$145.58 - $192.14 $44,984 - $59,371
-309 Reduced 8.47%
3,339 $486,000
Q2 2021

Aug 11, 2021

BUY
$134.22 - $202.37 $208,846 - $314,887
1,556 Added 74.38%
3,648 $714,000
Q1 2021

May 10, 2021

BUY
$140.25 - $196.86 $293,403 - $411,831
2,092 New
2,092 $379,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.51B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Pictet & Cie (Europe) Sa Portfolio

Follow Pictet & Cie (Europe) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.